Revised mask-wearing requirements at our Medical Centre and Hospital

Clinico Pathology Conference (CPC): Asymptomatic Cholelithiasis, Don't Chop Can or Not?

25

Jul

2019 Thu

 

Thursday, 25 April 2019

 

12pm to 2pm (12pm-Lunch, 1pm–Talk)

 

Farrer Park Medical Centre, 1 Farrer Park Station Road, Connexion #16-06, TK Low Academic Specialist Centre, Singapore 217562

Gallstones are classically divided into cholesterol stones and bilirubinate stones, and their differences lie in the constituents as well as their mobility. With so many complications from 'asymptomatic' gallstones, it may be more important to use mobility to classify gallstones.

With patients seeking more autonomy and informed consent, it will be prudent for doctors to let patients know the pros and cons of not removing the gallstones.

Join us at our CME Lunch Talk, Clinico Pathology Conference (CPC) where cases will be presented to discuss the current management options available for the doctor.

*This session is open to doctors and healthcare professionals only. Thank you.


Join us at our CME Lunch Talk.

Call us to register or email us at [email protected].


Know more about our Speaker

Dr Stephen Chang

General Surgeon
GLAD Clinic (Gallbladder, Liver and Digestive), Farrer Park Medical Centre

Dr Stephen Chang is a general surgeon practicing at Farrer Park Hospital and Farrer Park Medical Centre Singapore. He subspecializes in laparoscopic surgery, management of gall bladder, liver and pancreatic diseases, and liver transplantation.

Dr Stephen Chang graduated with a Bachelor of Medicine, Bachelor of Surgery at the National University of Singapore (NUS) in 1994 and obtained his Master of Medicine (Surgery) in 2000 from NUS. Having become a fellow of the Royal College of Surgeons of Edinburgh, UK in 2003, he furthered his training in laparoscopic hepatobiliary and pancreatic surgery, and liver transplantation in Paris, France.

Dr Chang was a key developer of the laparoscopic approach to hepatobiliary and pancreatic surgery and has been active in developing the living donor liver transplant (LDLT) program. He also pioneered the single incision laparoscopic surgery (SILS) and was the first few to publish his experience in single incision laparoscopic gallbladder surgery, liver resection and pancreas resection.

Dr Chang is the founding president of the Hepatopancreatobiliary Association of Singapore and an adjunct associate professor at the Yong Loo Lin School of Medicine in NUS. Aside from his practice at Farrer Park Hospital, he is also a visiting senior consultant to the Division of Hepatobiliary and Pancreatic Surgery, University Surgical Cluster at the National University Hospital (NUH).

Academically, Dr Chang's research interests not only include clinical research but also basic science and medical technology (medtech) development. He has held numerous research grant awards totaling more than $7 million to develop new surgical techniques and treatment modalities through medical technological initiatives. He has extensive publications in both clinical and medtech research and has since filed 5 patents in these areas. With these endeavours, he hopes to improve the care of patients.